Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
ID
Sinreih, Maša
(
Author
),
ID
Jójárt, Rebeka
(
Author
),
ID
Kele, Zoltán
(
Author
),
ID
Büdefeld, Tomaž
(
Author
),
ID
Paragi, Gábor
(
Author
),
ID
Mernyák, Erzsébet
(
Author
),
ID
Lanišnik-Rižner, Tea
(
Author
)
PDF - Presentation file,
Download
(1,22 MB)
MD5: E7CF8F257893B62A5E5E898726A7C486
URL - Source URL, Visit
https://www.tandfonline.com/doi/full/10.1080/14756366.2021.1937142
Image galllery
Abstract
Enzymes AKR1C regulate the action of oestrogens, androgens, and progesterone at the pre-receptor level and are also associated with chemo-resistance. The activities of these oestrone halides were investigated on recombinant AKR1C enzymes. The oestrone halides with halogen atoms at both C-2 and C-4 positions (13β-, 13α-methyl-17-keto halogen derivatives) were the most potent inhibitors of AKR1C1. The lowest IC$_{50}$ values were for the 13α-epimers 2_2I,4Br and 2_2I,4Cl (IC$_{50}$, 0.7 μM, 0.8 μM, respectively), both of which selectively inhibited the AKR1C1 isoform. The 13α-methyl-17-keto halogen derivatives 2_2Br and 2_4Cl were the most potent inhibitors of AKR1C2 (IC$_{50}$, 1.5 μM, 1.8 μM, respectively), with high selectivity for the AKR1C2 isoform. Compound 1_2Cl,4Cl showed the best AKR1C3 inhibition, and it also inhibited AKR1C1 (Ki: AKR1C1, 0.69 μM; AKR1C3, 1.43 μM). These data show that halogenated derivatives of oestrone represent a new class of potent and selective AKR1C inhibitors as lead compounds for further optimisations.
Language:
English
Keywords:
aldo-keto reductases
,
inhibition
,
halogenated oestrone derivatives
,
structure–activity relationships
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2021
Number of pages:
Str. 1499–1507
Numbering:
Vol. 36, no. 1
PID:
20.500.12556/RUL-144791
UDC:
616-006
ISSN on article:
1475-6366
DOI:
10.1080/14756366.2021.1937142
COBISS.SI-ID:
67617027
Publication date in RUL:
13.03.2023
Views:
586
Downloads:
57
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Journal of enzyme inhibition and medicinal chemistry
Shortened title:
J. enzyme inhib. med. chem.
Publisher:
Taylor & Francis
ISSN:
1475-6366
COBISS.SI-ID:
512255001
Licences
License:
CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:
http://creativecommons.org/licenses/by-nc/4.0/
Description:
A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.
Secondary language
Language:
Slovenian
Keywords:
aldo-keto reduktaze
,
halogenirani derivati estrona
,
zaviranje
Projects
Funder:
Other - Other funder or multiple funders
Funding programme:
Hungarian Academy of Sciences, János Bolyai Research Scholarship
Funder:
Other - Other funder or multiple funders
Funding programme:
National Research, Development and Innovation Office (NKFIH)
Project number:
OTKA SNN 124329
Funder:
ARRS - Slovenian Research Agency
Project number:
N1-0066
Name:
Razvoj novih derivatov estrona kot intrakrinih modulatorjev sinteze in transporta estrogenov
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back